Scholtz & Company’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNLX
GGHC
PGM
GIM
FAM
ACH
PA
GG
PCM
Scholtz & Company's RNLX Position: Q3 2021 in Review
Scholtz & Company sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2021, closing a stake of 87,975 shares — an estimated $2.71M sold.
Scholtz & Company first reported a position in RNLX in Q4 2020 and held it in 3 quarters. The position peaked at $2.71M in Q2 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q3 2021.
- Scholtz & Company reported no remaining Renalytix plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
- Scholtz & Company sold 87,975 Renalytix plc American Depositary Shares shares in Q3 2021, an estimated $2.71M.
- Scholtz & Company first reported a position in Renalytix plc American Depositary Shares in Q4 2020 and held it in 3 quarters.
- Scholtz & Company's Renalytix plc American Depositary Shares position peaked at $2.71M in Q2 2021.
- 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2021.
Based on Scholtz & Company's 13F filing for Q3 2021, filed 15 Nov 2021.